The regulations include rules on the registration and required training for physicians who would like to certify patients for Alabama’s medical cannabis program, which was signed into law by Gov. Kay Ivey in May.
According to the draft rules, physicians can recommend medical cannabis as a treatment for the following conditions after other medical treatment or therapy has failed:
Autism Spectrum Disorder (ASD)Cancer-related cachexia, nausea or vomiting, weight loss, or chronic painCrohn’s DiseaseDepressionEpilepsy or a condition causing seizuresHIV/AIDS-related nausea or weight lossPanic disorderParkinson’s diseasePersistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy, cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndromePost-Traumatic Stress Disorder (PTSD)Sickle Cell AnemiaSpasticity associated with a motor neuron disease, including Amyotrophic Lateral Sclerosis (ALS)Spasticity associated with Multiple Sclerosis (MS) or a spinal cord injuryA terminal illnessTourette’s SyndromeA condition causing chronic or intractable pain in which conventional intervention and opiate therapy is contraindicated or has proved ineffective
The Alabama State Board of Medical Examiners will accept public comment on the draft rules through Jan. 4, 2022.
The Alabama Medical Cannabis Commission is also working on its own regulations regarding the licensing of cultivators, manufacturers and dispensaries, according to the press release.